Compare · CTSH vs GDRX
CTSH vs GDRX
Side-by-side comparison of Cognizant Technology Solutions Corporation (CTSH) and GoodRx Holdings Inc. (GDRX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CTSH and GDRX operate in EDP Services (Technology), so they compete in similar markets.
- CTSH is the larger of the two at $28.41B, about 24.0x GDRX ($1.19B).
- GDRX has been more active in the news (10 items in the past 4 weeks vs 3 for CTSH).
- Both have 25 recent analyst ratings on file.
- Company
- Cognizant Technology Solutions Corporation
- GoodRx Holdings Inc.
- Price
- -
- -
- Market cap
- $28.41B
- $1.19B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- EDP Services
- EDP Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1998
- 2020
- News (4w)
- 3
- 10
- Recent ratings
- 25
- 25
Cognizant Technology Solutions Corporation
Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally. The company operates through four segments: Financial Services; Healthcare; Products and Resources; and Communications, Media and Technology. It offers customer experience enhancement, robotic process automation, analytics, and AI services in areas, such as digital lending, fraud detection, and next generation payments; and enhanced compliance, integrated health management, claims investigative services, and patient experience, as well as services that drive operational improvements in areas, such as claims processing, enrollment, membership, and billing to healthcare providers and payers, and life sciences companies, including pharmaceutical, biotech, and medical device companies. The company also provides solution to manufacturers, retailers and travel and hospitality companies, as well as companies providing logistics, energy and utility services; and cloud, interactive, and IoT services to information, media and entertainment, and communications and technology companies. Cognizant Technology Solutions Corporation was founded in 1994 and is headquartered in Teaneck, New Jersey.
GoodRx Holdings Inc.
GoodRx Holdings, Inc., through its subsidiaries, provides information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including telehealth services. The company serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.
Latest CTSH
- Cognizant and Benchling Selected as Partners to Accelerate Kyowa Kirin's R&D
- CLO, CAO & Corporate Secretary Kim John Sunshin sold $142,625 worth of shares (2,500 units at $57.05) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 40,392 units (SEC Form 4)
- Chief Financial Officer Dalal Jatin P sold $669,168 worth of shares (12,000 units at $55.76) as part of a pre-agreed trading plan, decreasing direct ownership by 21% to 46,111 units (SEC Form 4)
- SEC Form 10-Q filed by Cognizant Technology Solutions Corporation
- Cognizant Technology Solutions Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Cognizant Reports Second Quarter 2026 Results
- Cognizant launches EMEA AI Unit to help enterprises scale agentic AI adoption
- The Andover Companies Selects Cognizant to Modernize Technology and Advance AI-Driven Innovation
- Cognizant and Anthropic expand partnership to embed Claude in Cognizant's industry platforms, helping clients close the gap between AI promise and business outcomes
- Cognizant and Gulf Edge Announce Strategic Partnership to Accelerate Enterprise AI Adoption in Southeast Asia
Latest GDRX
- Large owner Francisco Partners Iv, L.P. converted options into 7,500,000 shares, disposed of 4,739,005 shares and sold $4,201,230 worth of shares (1,193,951 units at $3.52) (SEC Form 4)
- SEC Form 144 filed by GoodRx Holdings Inc.
- Chief Accounting Officer Chan Thomas (Tc) converted options into 10,115 shares and covered exercise/tax liability with 5,149 shares, increasing direct ownership by 58% to 13,546 units (SEC Form 4)
- Officer Fengler Justin converted options into 48,532 shares and covered exercise/tax liability with 21,407 shares, increasing direct ownership by 115% to 50,776 units (SEC Form 4)
- SEC Form 4 filed by Officer Fengler Justin
- New insider Fengler Justin claimed ownership of 23,651 shares (SEC Form 3)
- GoodRx Holdings Inc. filed SEC Form 8-K: Leadership Update
- SEC Form 10-Q filed by GoodRx Holdings Inc.
- GoodRx Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GoodRx Reports Second Quarter 2026 Results